News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Paolo Tarantino: Final OS from BROCADE3 phase 3 trial
Photo of Paolo Tarantino from X
Feb 10, 2024, 08:06

Paolo Tarantino: Final OS from BROCADE3 phase 3 trial

Paolo Tarantino, Medical Oncologist, Research Fellow at Dana-Farber Cancer Institute, shared a post on X/Twitter:

“Final OS from BROCADE3 phase 3 trial: adding veliparib to 1L carbo-taxol did not improve OS in BRCA-mutant patients with advanced TNBC. Notably, mPFS (>12 months) and mOS (≃30 months) were longer than expected. Effect of the carbo-taxol combo, or chance?”

Paolo Tarantino: Final OS from BROCADE3 phase 3 trial

Visit the article website.
Source: Paolo Tarantino/X

BRCA Breast Cancer BROCADE3 cancer OncoDaily Oncology Paolo Tarantino TNBC veliparib
Special Coverage
Blog
Feb 22, 2025, 14:43
Giannis Mountzios: How active ADCs against oncogene-addicted NSCLC?
Science
Feb 22, 2025, 14:10
Yan Leyfman: Advancing CAR T-Cell Therapy - Off-the-Shelf Allogeneic Approach
Science
Feb 22, 2025, 13:28
Elvina Almuradova: Immunotherapy for HPV-Associated Cancers
Opinion
Feb 22, 2025, 13:10
Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding
Science
Feb 22, 2025, 13:10
Why immunotherapy has struggled in EGFR+ lung cancer - EGFR Positive Lung Cancer UK
Blog
Feb 22, 2025, 13:04
Debate session on the management of stage III NSCLC in the IO era - ESTRO
Celebrities
Feb 22, 2025, 11:40
Remembering Saxophonist James Casey: His Battle with Colon Cancer and Advocacy
Career
Feb 22, 2025, 11:36
Joseph H. Antin Received ASTCT Lifetime Achievement Award at 2025 Tandem Meetings
Science
Feb 22, 2025, 11:28
Myeloma Paper of the Day, February 22nd, suggested by Robert Orlowski
Blog
Feb 22, 2025, 11:22
Yan Leyfman: Great experience speaking at the NSHSS Pre-Medicine Workshop
Insight
Feb 22, 2025, 11:15
Henrik Ullum: The urgent need to protect WHO is also an opportunity
Oncolibrary
Feb 22, 2025, 11:02
New Paper Alert: Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer